Federal Court finds Minister’s CSP decision unreasonable on patent eligibility for fixed-dose combination drug product
Federal Court determines that infringement action under PM(NOC) Regulations is not moot where trial proceeds after patent expiry
Federal Court issues first decision on patent term restoration – Minister’s decision denying certificate of supplementary protection (CSP) is unreasonable
Health Canada publishes new amendments to the Food and Drug Regulations and Medical Devices Regulations allowing for public release of clinical information in regulatory submissions
FCA Confirms that Non-Infringing Alternative Must be Legal and Objectively Economically Viable
Ontario Superior Court rejects Apotex attempts to revive the Promise Doctrine by dismissing motion for leave to amend, awards substantial indemnity costs
Health Canada Releases Updated Guidance on Amended PM(NOC) Regulations
Blogs
Firm/Org